Natural Beauty Bio-Technology Limited (NBBTF)
OTHER OTC:NBBTF
Total Valuation
Natural Beauty Bio-Technology has a market cap or net worth of $125.17M. The enterprise value is $1.20B.
Market Cap$125.17M
Enterprise Value$1.20B
Share Statistics
Natural Beauty Bio-Technology has 2,002,101,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,002,101,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Natural Beauty Bio-Technology’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 1.98%.
Return on Equity (ROE)0.02
Return on Assets (ROA)0.01
Return on Invested Capital (ROIC)1.98%
Return on Capital Employed (ROCE)0.03
Revenue Per Employee994.15K
Profits Per Employee19.52K
Employee Count542
Asset Turnover0.58
Inventory Turnover2.83
Valuation Ratios
The current PE Ratio of Natural Beauty Bio-Technology is 92.7. Natural Beauty Bio-Technology’s PEG ratio is -0.84.
PE Ratio92.7
PS Ratio1.82
PB Ratio2.07
Price to Fair Value2.07
Price to FCF-10.45
Price to Operating Cash Flow-38.23
PEG Ratio-0.84
Income Statement
In the last 12 months, Natural Beauty Bio-Technology had revenue of 538.83M and earned 10.58M in profits. Earnings per share was <0.01.
Revenue538.83M
Gross Profit269.54M
Operating Income17.69M
Pretax Income11.82M
Net Income10.58M
EBITDA56.48M
Earnings Per Share (EPS)<0.01
Cash Flow
In the last 12 months, operating cash flow was -25.66M and capital expenditures -68.25M, giving a free cash flow of -93.91M billion.
Operating Cash Flow-25.66M
Free Cash Flow-93.91M
Free Cash Flow per Share-0.05
Dividends & Yields
Natural Beauty Bio-Technology pays an annual dividend of <$0.001, resulting in a dividend yield of ―
Dividend Per Share<$0.001
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.03
52-Week Price Change1.72%
50-Day Moving Average0.06
200-Day Moving Average0.06
Relative Strength Index (RSI)51.84
Average Volume (3m)3.00K
Important Dates
Natural Beauty Bio-Technology upcoming earnings date is Aug 5, 2026, TBA (Confirmed).
Last Earnings DateMar 10, 2026
Next Earnings DateAug 5, 2026
Ex-Dividend Date―
Financial Position
Natural Beauty Bio-Technology as a current ratio of 1.11, with Debt / Equity ratio of 67.37%
Current Ratio1.11
Quick Ratio0.81
Debt to Market Cap0.31
Net Debt to EBITDA3.81
Interest Coverage Ratio1.69
Taxes
In the past 12 months, Natural Beauty Bio-Technology has paid 1.24M in taxes.
Income Tax1.24M
Effective Tax Rate0.10
Enterprise Valuation
Natural Beauty Bio-Technology EV to EBITDA ratio is 21.18, with an EV/FCF ratio of -12.74.
EV to Sales2.22
EV to EBITDA21.18
EV to Free Cash Flow-12.74
EV to Operating Cash Flow-46.61
Balance Sheet
Natural Beauty Bio-Technology has $112.12M in cash and marketable securities with $319.30M in debt, giving a net cash position of -$207.18M billion.
Cash & Marketable Securities$112.12M
Total Debt$319.30M
Net Cash-$207.18M
Net Cash Per Share-$0.10
Tangible Book Value Per Share$0.24
Margins
Gross margin is 50.02%, with operating margin of 3.28%, and net profit margin of 1.96%.
Gross Margin50.02%
Operating Margin3.28%
Pretax Margin2.19%
Net Profit Margin1.96%
EBITDA Margin10.48%
EBIT Margin3.28%
Analyst Forecast
The average price target for Natural Beauty Bio-Technology is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―